ACUTA CAPITAL PARTNERS, LLC - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 61 filers reported holding EDGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$8,844,000
-34.2%
943,906
-24.7%
1.67%
-30.7%
Q3 2017$13,449,000
-12.9%
1,253,394
-16.7%
2.41%
-44.2%
Q2 2017$15,437,000
+25.4%
1,504,612
+11.3%
4.32%
+48.0%
Q1 2017$12,312,000
-5.3%
1,351,516
+29.9%
2.92%
-39.6%
Q4 2016$13,003,000
+77.7%
1,040,265
+48.0%
4.84%
+75.9%
Q3 2016$7,318,000
+36.6%
703,000
+32.6%
2.75%
+6.7%
Q2 2016$5,358,000
+52.0%
530,000
+37.6%
2.58%
+30.6%
Q1 2016$3,524,000
+77.5%
385,100
+142.5%
1.97%
+107.7%
Q4 2015$1,985,000158,8070.95%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$21,362,00010.94%
VHCP Management II, LLC 1,933,582$17,615,0007.21%
ACUTA CAPITAL PARTNERS, LLC 1,351,516$12,312,0002.92%
Opaleye Management Inc. 280,000$2,550,0001.27%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,367,0000.27%
REGENTATLANTIC CAPITAL LLC 135,000$1,230,0000.11%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 15,401$140,0000.10%
TFS CAPITAL LLC 22,993$209,0000.07%
EAGLE ASSET MANAGEMENT INC 899,968$8,198,0000.05%
Trexquant Investment LP 15,669$143,0000.02%
View complete list of EDGE THERAPEUTICS INC shareholders